Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0Gut Microbes

Impact of Ruminococcus gnavus on lipid metabolism via isoCDCA

6 affiliations
  1. 1Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China
  2. 2Department of Clinical Pharmacology, Xiangya Hospital, Central South University, ChangSha, China
  3. 3Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
  4. 4National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, Hunan, China
  5. 5Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  6. 6Affiliated Hospital of Youjiang Medical College for Nationalities, Guangxi, China

Abstract

The gut microbiota is increasingly recognized as a regulator of host lipid metabolism, yet the specific strains and effector metabolites driving hyperlipidemia remain poorly defined. Here, we identified Ruminococcus gnavus (R. gnavus) as a candidate contributor to cholesterol-related dyslipidemia and delineated its metabolic mechanism. Comparing individuals with high versus normal TC/LDL-C (HTL vs NTL) in both normal-weight and overweight populations, we found that fecal R. gnavus was enriched in HTL individuals regardless of BMI stratum, a finding validated by species-specific qPCR in an independent cohort (n = 488). Administering R. gnavus to mice fed a normal or high-fat diet induced alterations in circulating lipids and liver function markers, accompanied by hepatic steatosis. Hepatic transcriptomics and targeted bile acid profiling converged on bile acid metabolism: R. gnavus downregulated key hepatic genes (Cyp7a1, Cyp8b1, Ldlr, and Ppara) and elevated isochenodeoxycholic acid (isoCDCA) levels both in vivo and in vitro. In vitro, R. gnavus directly converted chenodeoxycholic acid (CDCA) to isoCDCA. Clinically, serum isoCDCA was elevated in HTL individuals in an independent cohort (n = 1,137) and was positively associated with TC, TG, and LDL-C. Functionally, oral isoCDCA supplementation reproduced key lipid disturbances in mice, and isoCDCA downregulated lipid metabolism genes and promoted lipid accumulation in hepatocytes; heterologous expression of R. gnavus hydroxysteroid dehydrogenases conferred isoCDCA-producing capacity on E. coli and elevated circulating TC and LDL-C in colonized mice. These findings nominate isoCDCA as a microbial effector metabolite linking R. gnavus to hepatic lipid dysregulation and identify the R. gnavus–isoCDCA axis as a potential target for the prevention and treatment of hyperlipidemia.

Related

  1. M6A modification in lipid metabolism and related diseases
    Zhiwen Hu, Didi Yuan, Xi Feng +1
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. Emerging Roles of Non-coding RNAs in the Regulation of Lipid Metabolism in Podocytes
    Keyi Du, Lili Zhou
    Journal of Lipid ResearchPeer-reviewedLicence not statedEnzymology & metabolismCrossref
  3. Lipid remodeling during phosphate starvation in plants: from metabolism to inter-organelle lipid transport
    Siqi Yan, Samia Alsayyad, Morgane Michaud
    BiochimiePeer-reviewedCC BY 4.0Full textEnzymology & metabolismHAL
  4. ALOX15 links lipid metabolism to receptor trafficking in platelet activation
    Yosef Eshetie Amare, Sharad Saxena, Serena Zacchigna
    The Febs JournalPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  5. Metabolic reprogramming in macrophages: the central role of lipid metabolism in bone homeostasis.
    Longping Li, Yuxiao Zhang, Shuo Huang +8
    Bone researchPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
BibTeX
@article{peng2026impact,
  title = {{Impact of Ruminococcus gnavus on lipid metabolism via isoCDCA}},
  author = {Yi-Lei Peng and Ya-Yi Xiao and Si-Jin Yin and Hong-Hao Zhou and Wei Zhang and Peng Zhu and Qing Li},
  journal = {Gut Microbes},
  year = {2026},
  month = nov,
  doi = {10.1080/19490976.2026.2753210},
  url = {https://doi.org/10.1080/19490976.2026.2753210},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Impact of Ruminococcus gnavus on lipid metabolism via isoCDCA
AU  - Yi-Lei Peng
AU  - Ya-Yi Xiao
AU  - Si-Jin Yin
AU  - Hong-Hao Zhou
AU  - Wei Zhang
AU  - Peng Zhu
AU  - Qing Li
PY  - 2026
DA  - 2026/11/10
JO  - Gut Microbes
DO  - 10.1080/19490976.2026.2753210
UR  - https://doi.org/10.1080/19490976.2026.2753210
AB  - The gut microbiota is increasingly recognized as a regulator of host lipid metabolism, yet the specific strains and effector metabolites driving hyperlipidemia remain poorly defined. Here, we identified Ruminococcus gnavus (R. gnavus) as a candidate contributor to cholesterol-related dyslipidemia and delineated its metabolic mechanism. Comparing individuals with high versus normal TC/LDL-C (HTL vs NTL) in both normal-weight and overweight populations, we found that fecal R. gnavus was enriched in HTL individuals regardless of BMI stratum, a finding validated by species-specific qPCR in an independent cohort (n = 488). Administering R. gnavus to mice fed a normal or high-fat diet induced alterations in circulating lipids and liver function markers, accompanied by hepatic steatosis. Hepatic transcriptomics and targeted bile acid profiling converged on bile acid metabolism: R. gnavus downregulated key hepatic genes (Cyp7a1, Cyp8b1, Ldlr, and Ppara) and elevated isochenodeoxycholic acid (isoCDCA) levels both in vivo and in vitro. In vitro, R. gnavus directly converted chenodeoxycholic acid (CDCA) to isoCDCA. Clinically, serum isoCDCA was elevated in HTL individuals in an independent cohort (n = 1,137) and was positively associated with TC, TG, and LDL-C. Functionally, oral isoCDCA supplementation reproduced key lipid disturbances in mice, and isoCDCA downregulated lipid metabolism genes and promoted lipid accumulation in hepatocytes; heterologous expression of R. gnavus hydroxysteroid dehydrogenases conferred isoCDCA-producing capacity on E. coli and elevated circulating TC and LDL-C in colonized mice. These findings nominate isoCDCA as a microbial effector metabolite linking R. gnavus to hepatic lipid dysregulation and identify the R. gnavus–isoCDCA axis as a potential target for the prevention and treatment of hyperlipidemia.
SN  - 1949-0976
SN  - 1949-0984
ER  -